Skip to main content

Table 2 Isolated bacteria by intervention group

From: Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units

 

No oral switch (n = 238)

Oral switch (n = 111)

All (n = 349)

P-value

N

%

N

%

N

%

Negative

129

54%

76

69%

205

59%

0.024

Gram-negative

72

30%

17

15%

  

0.027

Enterobacter spp.

23

10%

4

4%

16

5%

0.139

  Multisusceptible

7

 

4

 

11

  

  ESBL-producing

16

 

0

 

16

  

Escherichia coli

14

6%

4

4%

18

5%

0.531

  Multisusceptible

14

 

4

 

18

  

Klebsiella spp.

12

5%

3

3%

15

4%

0.468

  Multisusceptible

4

 

3

 

7

  

  Carbapenemase-producing

8

 

0

 

8

  

Pseudomonas aeruginosa

11

5%

2

2%

13

4%

0.332

  Multisusceptible

11

 

2

 

13

  

Serratia spp.

6

3%

1

1%

7

2%

0.449

  Multisusceptible

6

 

1

 

7

  

Acinetobacter baumannii

0

0%

1

1%

1

0%

Proteus spp.

1

0%

1

1%

2

1%

0.433

  Multisusceptible

1

0%

1

1%

2

  

Burkholderia cepacia

2

1%

0

0%

2

1%

Aeromonas hydrophila

1

0%

1

1%

2

1%

0.433

Citrobacter spp.

1

0%

0

0%

1

0%

Haemophilus spp.

1

0%

0

0%

1

0%

0.433

Gram-positive

26

11%

15

14%

  

0.027

Stenotrophomonas maltophilia

1

0%

1

1%

2

1%

0.433

Listeria monocytogenes

1

0%

0

0%

1

0%

CN Staphylococcus

0

0%

1

1%

1

0%

0.433

Staphylococcus aureus

14

6%

6

5%

20

6%

0.372

  MSSA

5

2%

3

3%

8

2%

 

  MRSA

9

4%

3

3%

12

3%

 

Streptococcus pneumoniae

4

2%

4

4%

8

2%

0.097

Enterococcus spp.

4

2%

1

1%

4

1%

0.403

Streptococcus spp.

1

0%

1

1%

2

1%

0.433

Others

Pneumocystis jirovecii

0

0%

1

1%

1

0%

Candida albicans

1

0%

0

0%

1

0%

 Polymicrobial

2

1%

0

0%

2

1%

Total

238

100%

110

100%

348

  
  1. ESBL Extended-spectrum beta-lactamases, MSSA Methicillin-susceptible Staphylococcus aureus, MRSA Methicillin-resistant Staphylococcus aureus, CN Coagulase negative